Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

CTech 24/7

InMode

5 stories about InMode

Medical Aesthetic Company InMode in Talks for Secondary Offering
23.12.19|Golan HazaniThe Israel-based company listed on Nasdaq in August at a $450 million company valuation but has since reached a $1.3 billion market capitalization
Dreams of Eternal Youth Boost InMode’s Valuation
04.11.19|Sophie ShulmanThe medical aesthetic devices manufacturer doubled its market capitalization since its August IPO on Nasdaq, passing the $1 billion mark this past weekend
Medical Aesthetic Device Manufacturer InMode Raises $70 Million on Nasdaq IPO
11.08.19|Golan HazaniInMode priced its shares at $14, the lower end of its previously suggested range, giving the company a pre-money valuation of $378 million
Medical Aesthetic Devices Manufacturer InMode Looking to Raise $75 Million on Nasdaq
14.07.19|CTechIn June, Calcalist reported that InMode is looking to list on Nasdaq according to a company valuation of $400 million to $500 million
Medical Aesthetic Devices Manufacturer InMode Gearing Up for Nasdaq IPO
03.06.19|Golan HazaniInMode develops devices that use radio-frequency energy technology, capable of penetrating subdermal fat

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

InMode

Medical Aesthetic Company InMode in Talks for Secondary Offering

Dreams of Eternal Youth Boost InMode’s Valuation

Medical Aesthetic Device Manufacturer InMode Raises $70 Million on Nasdaq IPO

Medical Aesthetic Devices Manufacturer InMode Looking to Raise $75 Million on Nasdaq

Medical Aesthetic Devices Manufacturer InMode Gearing Up for Nasdaq IPO